Edition:
India

John Miller

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

16 Oct 2020

ZURICH/GENEVA A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19.

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

16 Oct 2020

ZURICH/GENEVA A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19.

Clariant re-launches pigments unit sale, with multiple bidders: sources

15 Oct 2020

FRANKFURT/ZURICH Clariant is relaunching the sale of its pigments unit, after putting the auction on hold as the coronavirus pandemic engulfed the world and disrupted talks with prospective buyers, the Swiss speciality chemicals company said on Thursday.

UPDATE 3-Roche diagnostics business surges as COVID-19 infections rise

15 Oct 2020

* Countries already buying millions of antigen tests (Adds comments from diagnostics chief, analyst comment)

WHO fears spike in deaths after global COVID-19 surge

15 Oct 2020

GENEVA/ZURICH The World Health Organization (WHO) on Wednesday warned against any complacency in the coronavirus death rate, saying with the increasing number of cases, mortality would also rise.

WHO fears spike in deaths after global COVID-19 surge

14 Oct 2020

GENEVA/ZURICH The World Health Organization (WHO) on Wednesday warned against any complacency in the coronavirus death rate, saying with the increasing number of cases, mortality would also rise.

Countries turn to rapid antigen tests to contain second wave of COVID-19

14 Oct 2020

ZURICH/BERLIN Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those infected quickly.

Countries turn to rapid antigen tests to contain second wave of COVID-19

13 Oct 2020

ZURICH/BERLIN Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those infected quickly.

CORRECTED-Countries turn to rapid antigen tests to contain second wave of COVID-19

13 Oct 2020

ZURICH/BERLIN, Oct 13 Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those infected quickly.

World News